Medtronic plc
MDT · NYSE · CIK 0001613103
SIC 3845
Electromedical & Electrotherapeutic Apparatus
Category
Other
Entity
operating
Incorp.
-
Fiscal Y/E
0424
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
ROE
9.71%
ROA
5.09%
D/E Ratio
0.90
Current Ratio
1.85
Gross Margin
11.13%
Operating Margin
17.76%
Net Margin
13.90%
Book Value/Share
$37.46
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2025-06-20
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 33,537 | 32,364 | 31,227 | 31,686 | 30,117 |
| Cost of Revenue | 11,632 | 11,216 | 10,719 | 10,145 | 10,483 |
| Operating Income | 5,955 | 5,144 | 5,485 | 5,752 | 4,484 |
| Net Income | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 |
| EPS (Basic) | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 |
| EPS (Diluted) | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 91,680 | 89,981 | 90,948 | 90,981 | 93,083 |
| Current Assets | 23,814 | 21,935 | 21,675 | 23,059 | 22,548 |
| Cash & Equivalents | 2,218 | 1,284 | 1,543 | 3,714 | 3,593 |
| Total Liabilities | 43,424 | 39,561 | 39,283 | 38,260 | 41,481 |
| Current Liabilities | 12,879 | 10,789 | 9,051 | 12,394 | 8,509 |
| Total Equity | 48,024 | 50,214 | 51,483 | 52,551 | 51,428 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 7,044 | 6,787 | 6,039 | 7,346 | 6,240 |
| Investing CF | -1,937 | -2,366 | -3,493 | -1,659 | -2,866 |
| Financing CF | -4,361 | -4,450 | -4,960 | -5,336 | -4,136 |
| CapEx | 1,859 | 1,587 | 1,459 | 1,368 | 1,355 |
| Dividends Paid | 3,589 | 3,666 | 3,616 | 3,383 | 3,120 |
📄 SEC Filings
Current Report
8-K
2026-04-27
Open →
Current Report
8-K
2026-03-24
Open →
Quarterly Report
10-Q
2026-02-24
Open →
Current Report
8-K
2026-02-17
Open →
Quarterly Report
10-Q
2025-11-25
Open →
Current Report
8-K
2025-11-18
Open →
Current Report
8-K
2025-11-03
Open →
Current Report
8-K
2025-10-21
Open →
Current Report
8-K
2025-09-29
Open →
Current Report
8-K
2025-09-16
Open →
Quarterly Report
10-Q
2025-08-26
Open →
Proxy Statement
DEF 14A
2025-08-25
Open →
Current Report
8-K
2025-08-19
Open →
Current Report
8-K
2025-06-23
Open →
Annual Report
10-K
2025-06-20
Open →
Current Report
8-K
2025-05-21
Open →
Other filings (84)
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-05-06
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-28
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
S-3ASR
S-3ASR
2026-03-09
Open →
3
FORM 3
2026-03-05
Open →
Insider Transaction
FORM 4
2026-03-05
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-24
Open →
144
xsl144X01/primary_doc.xml
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-02
Open →
SCHEDULE 13D
xslSCHEDULE_13D_X01/primary_doc.xml
2026-01-29
Open →
3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-01-29
Open →
Insider Transaction
FORM 4
2025-12-17
Open →
Insider Transaction
FORM 4
2025-12-17
Open →
Insider Transaction
FORM 4
2025-12-17
Open →
Insider Transaction
FORM 4
2025-12-09
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-12-03
Open →
IRANNOTICE
IRANNOTICE
2025-11-25
Open →
Insider Transaction
FORM 4
2025-11-24
Open →
Insider Transaction
FORM 4
2025-11-21
Open →
144
xsl144X01/primary_doc.xml
2025-11-19
Open →
11-K/A
11-K/A
2025-10-24
Open →
11-K/A
11-K/A
2025-10-24
Open →
11-K
11-K
2025-10-20
Open →
11-K
11-K
2025-10-20
Open →
25-NSE
xslF25X02/primary_doc.xml
2025-10-15
Open →
25-NSE
xslF25X02/primary_doc.xml
2025-09-29
Open →
CERT
NYSE CERTIFICATION
2025-09-29
Open →
8-A12B
8-A12B
2025-09-29
Open →
424B5
424B5
2025-09-16
Open →
FWP
FWP
2025-09-15
Open →
424B3
424B3
2025-09-15
Open →
Insider Transaction
FORM 4
2025-09-05
Open →
ARS
ARS
2025-09-04
Open →
144
xsl144X01/primary_doc.xml
2025-09-03
Open →
IRANNOTICE
IRANNOTICE
2025-08-26
Open →
Insider Transaction
FORM 4
2025-08-25
Open →
DEFA14A
DEFA14A
2025-08-25
Open →
Insider Transaction
FORM 4
2025-08-21
Open →
3
FORM 3
2025-08-19
Open →
3
FORM 3
2025-08-19
Open →
PRE 14A
PRE 14A
2025-08-05
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-04
Open →
Insider Transaction
FORM 4
2025-08-01
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-30
Open →
3
FORM 3
2025-07-28
Open →
3
FORM 3
2025-07-02
Open →
25-NSE
xslF25X02/primary_doc.xml
2025-07-02
Open →
IRANNOTICE
IRANNOTICE
2025-06-20
Open →
144
xsl144X01/primary_doc.xml
2025-06-06
Open →
Insider Transaction
FORM 4
2025-06-04
Open →
3
FORM 3
2025-06-04
Open →
SD
SD
2025-05-28
Open →
Insider Transaction
FORM 4
2025-05-05
Open →
Insider Transaction
FORM 4
2025-04-30
Open →
Insider Transaction
FORM 4
2025-04-30
Open →